Noscapine-bile acid hybrids as novel anticancer agentsShow others and affiliations
2025 (English)In: RSC Medicinal Chemistry, E-ISSN 2632-8682, Vol. 16, no 11, p. 5511-5533Article in journal (Refereed) Epub ahead of print
Abstract [en]
Twenty novel noscapinoid-triterpene conjugate derivatives were designed and synthesized. Four noscapine derivatives (as secondary amine) and five bile acids were applied for the synthesis of a diverse library. The synthetic compounds were evaluated for their antiproliferative activity against PC3, A549, HepG2, Caki-1, U138MG, and MRC5. This study identified eight potent cytotoxic agents (7e-7i, 7k, 7m, and 7o) possessing more than 80% cell viability. Compounds 7e and 7f exhibited the highest cytotoxic activity against Caki-1 with IC<inf>50</inf> values of 260 nM and 350 nM, respectively. Western blot analysis results indicated that the eight hit compounds decreased the α-tubulin and β-actin levels in A549 cells, and further cellular assays on A549 demonstrated that 7e and 7f significantly inhibited cell migration, induced pronounced G1 cell-cycle arrest (with 7f also showing a minor G2/M increase) and triggered marked apoptosis, with 7e showing the strongest pro-apoptotic effect.
Place, publisher, year, edition, pages
Royal Society of Chemistry (RSC) , 2025. Vol. 16, no 11, p. 5511-5533
National Category
Organic Chemistry Medicinal Chemistry
Identifiers
URN: urn:nbn:se:kth:diva-372448DOI: 10.1039/d5md00570aISI: 001574478100001PubMedID: 40980425Scopus ID: 2-s2.0-105018608695OAI: oai:DiVA.org:kth-372448DiVA, id: diva2:2012152
Note
QC 20251107
2025-11-072025-11-072025-12-15Bibliographically approved